Pareto analyst Filip Wiberg downgraded Xvivo Perfusion (XVIPF) to Hold from Buy with a price target of SEK 500, down from SEK 560. The firm says it is time for the shares to “take a breather.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Questions or Comments about the article? Write to editor@tipranks.com